Developers who produce new cell-based therapies face unique challenges compared to traditional molecule development. Because the final drugs are the cells themselves, they must screen and validate each new culture condition during production, including raw materials and process parameters. To identify and maintain cell product quality throughout production, scientists combine high-throughput instruments and optimized reagents in a reliable screening platform.

Download this ebook from Sartorius to learn how to achieve scalable experimental design, reagent selection, cell characterization, and data analysis for cell therapy product screening and validation. 

Sponsored by